Surgical therapy for metastatic disease to the liver.

The liver is a common site of hematogenous metastasis. In the past, patients with liver metastases were often deemed inoperable, and medical therapy conferred only minor survival benefit. However, advances in surgical techniques and chemotherapeutic agents during the past two decades have led to effective treatments for selected patients with metastases to the liver. Up to approximately 80% of the liver can be resected, and partial hepatectomy is now routinely performed with a perioperative mortality rate of <5%. Surgical resection of colorectal cancer metastatic to the liver results in a 5-year survival rate of 40%. These results are expected to improve even further with multimodality approaches that include newer chemotherapy regimens. Liver metastases from other primary tumors, such as neuroendocrine carcinoma and genitourinary tumors, are also treated effectively with liver resection. The indications for surgical treatment of liver metastases are broadening as a variety of novel therapies are being developed, including hepatic artery embolization, hepatic artery infusion of chemotherapy, and radiofrequency ablation.

[1]  L. Mortelmans,et al.  Clinical value of whole‐body positron emission tomography with [18F]fluorodeoxyglucose in recurrent colorectal cancer , 1994, The British journal of surgery.

[2]  N. Kemeny,et al.  Evaluation of chest computed tomography in the staging of patients with potentially resectable liver metastases from colorectal carcinoma , 1999, Cancer.

[3]  Steven A Curley,et al.  Radiofrequency ablation , 2004, Cancer.

[4]  M. D'Angelica,et al.  Ninety-six five-year survivors after liver resection for metastatic colorectal cancer. , 1997, Journal of the American College of Surgeons.

[5]  W. Jarnagin,et al.  Recent advances in hepatic resection. , 2000, Seminars in surgical oncology.

[6]  D. Nagorney,et al.  Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. , 2003, Journal of the American College of Surgeons.

[7]  T. Pawlik,et al.  Combined Resection and Radiofrequency Ablation for Advanced Hepatic Malignancies: Results in 172 Patients , 2003, Annals of Surgical Oncology.

[8]  K. Batts,et al.  Hepatic resection for metastatic neuroendocrine carcinomas. , 1995, American journal of surgery.

[9]  S Bengmark,et al.  The natural history of primary and secondary malignant tumors of the liver I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy , 1969, Cancer.

[10]  Michael A. Choti,et al.  Trends in Long-Term Survival Following Liver Resection for Hepatic Colorectal Metastases , 2002, Annals of surgery.

[11]  J. Melendez,et al.  Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction. , 1998, Journal of the American College of Surgeons.

[12]  S. Yasuda,et al.  Prophylactic hepatic arterial infusion chemotherapy for the prevention of liver metastasis in patients with colon carcinoma , 2004, Cancer.

[13]  P. Schlag,et al.  Resection of liver metastases in colorectal cancer--competitive analysis of treatment results in synchronous versus metachronous metastases. , 1990, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[14]  Ronald P. DeMatteo,et al.  Anatomie segmental hepatic resection is superior to wedge resection as an oncologic operation for colorectal liver metastases , 2000, Journal of Gastrointestinal Surgery.

[15]  F. R. Watson,et al.  Factors influencing survival in patients with untreated hepatic metastases. , 1968, Surgery, gynecology & obstetrics.

[16]  N. Kemeny,et al.  A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer , 1992, Cancer.

[17]  B. Nordlinger,et al.  Survival benefit of repeat liver resections for recurrent colorectal metastases: 143 cases. Association Francaise de Chirurgie. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  L H Blumgart,et al.  Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. , 1999, The New England journal of medicine.

[19]  H. Bismuth,et al.  Intraoperative ultrasonographic study of the liver. Methods and anatomic results. , 1985, American journal of surgery.

[20]  J. Emond,et al.  Utility of operative ultrasound in the surgical management of liver tumors. , 1986, Annals of surgery.

[21]  V. Servois,et al.  Treatment of liver metastases from uveal melanoma by combined surgery-chemotherapy. , 1998, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[22]  H. Bismuth,et al.  Repeat hepatectomy for colorectal liver metastases. , 1997, Annals of surgery.

[23]  D L Morton,et al.  Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: a proposed algorithm. , 2000, Archives of surgery.

[24]  N. Kemeny,et al.  Role of chest CT in patients with negative chest X-rays referred for hepatic colorectal metastases , 2006, Annals of Surgical Oncology.

[25]  D. Elias,et al.  Hepatectomy for liver metastases from breast cancer. , 1995, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[26]  J. Fortner,et al.  Multivariate Analysis of a Personal Series of 247 Consecutive Patients with Liver Metastases from Colorectal Cancer: I. Treatment by Hepatic Resection , 1984, Annals of surgery.

[27]  D. Galetta,et al.  Biochemical modulation of fluorouracil with high dose methotrexate or folinic acid in advanced colorectal cancer patients. Gruppo Oncologico dell' Italia Meridionale (GOIM). , 1994, Anticancer Research.

[28]  R. Doci,et al.  Repeated hepatic resection for recurrent metastases from colorectal cancer , 1992, The British journal of surgery.

[29]  W. Jarnagin,et al.  Results of Hepatic Resection for Sarcoma Metastatic to Liver , 2001, Annals of surgery.

[30]  H. Wieand,et al.  Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  M. Adson,et al.  Surgical treatment of hepatic metastases from colorectal cancers. , 1976, Archives of surgery.

[32]  P. Rougier,et al.  Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  V. Sondak,et al.  Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. , 1996, Journal of the National Cancer Institute.

[34]  P. Piedbois Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  M. Burt,et al.  Resection of hepatic and pulmonary metastases from colorectal cancer. , 1992, Surgical oncology.

[36]  S. Curley,et al.  Repeat hepatic resection as effective treatment for recurrent colorectal liver metastases , 1997, Annals of Surgical Oncology.

[37]  S. Lipsitz,et al.  Abstracts reprinted from Journal of Clinical Oncology , 2002, Annals of Surgical Oncology.

[38]  M. Miyazaki,et al.  Benefits and limits of hepatic resection for gastric metastases. , 2001, American journal of surgery.

[39]  D. Nagorney,et al.  Cytoreductive hepatic surgery for neuroendocrine tumors. , 1990, Surgery.

[40]  Richard Stang,et al.  Resection of colorectal liver metastases , 1997, Journal of Gastrointestinal Surgery.

[41]  B. Cady,et al.  Surgical therapy for recurrent liver metastases from colorectal cancer. , 1990, Archives of surgery.

[42]  J. Faivre,et al.  Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer , 1995, The British journal of surgery.

[43]  A. Spencer,et al.  Repeat hepatectomy for cancer , 1993, The British journal of surgery.

[44]  H. Pitt,et al.  Should hepatic resections be performed at high-volume referral centers? , 2007, Journal of Gastrointestinal Surgery.

[45]  T. Hickish,et al.  Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[46]  B. Persson,et al.  Neuroendocrine metastases of the liver , 2004, World Journal of Surgery.

[47]  M. Callery,et al.  A critical appraisal of laparoscopic staging in hepatobiliary and pancreatic malignancy. , 2000, Surgical oncology.

[48]  M. Miyazaki,et al.  Hepatic resection of liver metastases from gastric carcinoma. , 1997, The American journal of gastroenterology.

[49]  B. Nordlinger,et al.  Repeat liver resection for recurrent colorectal metastases , 1993, The British journal of surgery.

[50]  L. Ellis,et al.  Radiofrequency Ablation of Unresectable Primary and Metastatic Hepatic Malignancies: Results in 123 Patients , 1999 .

[51]  D. Allison,et al.  Resection and embolization in the management of secondary hepatic tumors , 1982, World journal of surgery.

[52]  Y. Fong,et al.  Hepatic colorectal metastasis: current status of surgical therapy. , 1998, Oncology.

[53]  S. Larson,et al.  Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. , 1999, American journal of surgery.

[54]  L H Blumgart,et al.  Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. , 1999, Annals of surgery.

[55]  T. Starzl,et al.  Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. , 1994, Surgery.

[56]  P. Jönsson,et al.  Natural history of patients with untreated liver metastases from colorectal cancer. , 1981, American journal of surgery.

[57]  R. Goslin,et al.  Factors influencing survival in patients with hepatic metastases from adenocarcinoma of the colon or rectum , 1982, Diseases of the colon and rectum.

[58]  C. V. D. van de Velde,et al.  Diagnostic evaluation and survival analysis of colorectal cancer patients with liver metastases , 1987, Journal of surgical oncology.

[59]  Daniel J Sargent,et al.  A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[60]  F. Shamsa,et al.  Repeat liver resections from colorectal metastasis , 1995 .

[61]  F. Lévi,et al.  Five-Year Survival Following Hepatic Resection After Neoadjuvant Therapy for Nonresectable Colorectal [Liver] Metastases , 2001 .

[62]  D. Allegra,et al.  Radiofrequency Ablation in 447 Complex Unresectable Liver Tumors: Lessons Learned , 2003, Annals of Surgical Oncology.

[63]  C. Wilson,et al.  Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[64]  D. Ilstrup,et al.  Resection of hepatic metastases from colorectal cancer. , 1984, Archives of surgery.

[65]  M. Brennan,et al.  Repeat Hepatic Resections for Metastatic Colorectal Cancer , 1994, Annals of surgery.

[66]  L H Blumgart,et al.  A retrospective study of the natural history of patients with liver metastases from colorectal cancer. , 1976, Clinical oncology.

[67]  E. Van Cutsem,et al.  Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[68]  D. Ilstrup,et al.  The Natural History of Hepatic Metastases from Colorectal Cancer: A Comparison with Resective Treatment , 1984, Annals of surgery.

[69]  E Harrison,et al.  Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[70]  W. Jarnagin,et al.  Survival After Resection of Multiple Hepatic Colorectal Metastases , 2000, Annals of Surgical Oncology.

[71]  A. Jemal,et al.  Cancer Statistics, 2004 , 2004, CA: a cancer journal for clinicians.

[72]  Robert C. G. Martin,et al.  Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. , 2003, Journal of the American College of Surgeons.

[73]  M. Gonen,et al.  Second Liver Resections Are Safe and Effective Treatment for Recurrent Hepatic Metastases from Colorectal Cancer: A Bi-institutional Analysis , 2002, Annals of surgery.

[74]  L. Saltz,et al.  Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. , 2000, The New England journal of medicine.

[75]  D. Deziel,et al.  Synchronous, metachronous, and multiple hepatic resections of liver tumors originating from primary gastric tumors. , 1993, Surgery.

[76]  J. Berlin,et al.  Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[77]  J. Ranstam,et al.  Pattern of recurrence in liver resection for colorectal secondaries , 1987, World Journal of Surgery.

[78]  Katherine S. Virgo,et al.  Major Hepatic Resection: Indications and Results in a National Hospital System From 1988 to 1992 , 1997 .

[79]  A. Altendorf-Hofmann,et al.  Indicators of prognosis after hepatic resection for colorectal secondaries. , 1991, Surgery.

[80]  B. Cady,et al.  Survival of patients after colonic resection for carcinoma with simultaneous liver metastases. , 1970, Surgery, gynecology & obstetrics.

[81]  J. Bruce Kneeland,et al.  Hepatic metastases: CT versus MR imaging at 1.5T , 2005, Gastrointestinal Radiology.

[82]  F. Lévi,et al.  Hepatic resection after down-staging of unresectable hepatic colorectal metastases. , 2003, Surgical oncology clinics of North America.

[83]  W. Enker,et al.  Liver resection for colorectal metastases. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[84]  A. Altendorf-Hofmann,et al.  Factors influencing the natural history of colorectal liver metastases , 1994, The Lancet.

[85]  K. Hughes,et al.  Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. , 1986, Surgery.

[86]  D. Nagorney,et al.  Resection of ‘recurrent’ colorectal metastases to the liver , 1994, The British journal of surgery.

[87]  P. Rougier,et al.  Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[88]  M. Brennan,et al.  Hepatic resection for noncolorectal, nonneuroendocrine metastases: a fifteen-year experience with ninety-six patients. , 1997, Surgery.

[89]  J. Donohue,et al.  Hepatic resection for metastatic colorectal cancer results in cure for some patients. , 1997, Archives of surgery.

[90]  M. McCarter,et al.  Metastatic liver tumors. , 2000, Seminars in surgical oncology.

[91]  A. Benson,et al.  Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors. , 2001, Surgery.

[92]  B. Plaud,et al.  Resection of liver metastases from a noncolorectal primary: indications and results based on 147 monocentric patients. , 1998, Journal of the American College of Surgeons.

[93]  C. Balch,et al.  A multifactorial analysis of prognostic factors in patients with liver metastases from colorectal carcinoma. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[94]  J. Foster Survival after liver resection for secondary tumors. , 1978, American journal of surgery.

[95]  T. Sakaguchi,et al.  Impact of repeat hepatectomy on recurrent colorectal liver metastases. , 2001, Surgery.

[96]  Improvement in Perioperative Outcome After Hepatic Resection: Analysis of 1,803 Consecutive Cases Over the Past Decade , 2002 .

[97]  A Morabito,et al.  One hundred patients with hepatic metastases from colorectal cancer treated by resection: Analysis of prognostic determinants , 1991, The British journal of surgery.

[98]  B. Nordlinger,et al.  Hepatic Resection for Colorectal Liver Metastases: Influence on Survival of Preoperative Factors and Surgery for Recurrences in 80 Patients , 1987, Annals of surgery.

[99]  A. Bonetti Hepatic artery infusion for liver metastases from colorectal cancer , 2003, The Lancet.

[100]  C. Moertel,et al.  THE NATURAL HISTORY OF CARCINOMA OF THE COLON AND RECTUM. , 1964, American journal of surgery.

[101]  A. Altendorf-Hofmann,et al.  Hepatic metastases from colorectal carcinoma: Impact of surgical resection on the natural history , 1990, The British journal of surgery.

[102]  T. Fleming,et al.  Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[103]  D. Ilstrup,et al.  Perioperative Blood Transfusion and Determinants of Survival After Liver Resection for Metastatic Colorectal Carcinoma , 1992, Annals of surgery.

[104]  Peter Schlag,et al.  Resection of the liver for colorectal carcinoma metastases , 1988, Diseases of the colon and rectum.